EPIC Program Annual Data Tables 2006-2007: Table IX
| Rank by Payment | Drug and Strength | Drug Type** | Number of Claims | EPIC Payments | Rank by Number of Claims |
|---|---|---|---|---|---|
| Top 20 Totals | 2,135,579 | $214,417,516 | |||
| Percent of Top 20 Drugs to Total EPIC Payments | 19.00% | 31.97% | |||
| 1 | PLAVIX (75 MG) | SS | 290,161 | $37,575,242 | 1 |
| 2 | NEXIUM (40 MG) | SS | 106,826 | $18,736,004 | 13 |
| 3 | PREVACID (30 MG) | SS | 78,927 | $13,958,134 | 21 |
| 4 | PROTONIX (40 MG) | SS | 103,978 | $13,848,921 | 14 |
| 5 | LIPITOR (20 MG) | SS | 107,017 | $13,520,582 | 12 |
| 6 | LIPITOR (10 MG) | SS | 147,932 | $12,864,785 | 5 |
| 7 | FOSAMAX (70 MG) | SS | 129,090 | $10,160,619 | 7 |
| 8 | NORVASC (5 MG) | BNMS | 165,142 | $9,377,232 | 3 |
| 9 | NORVASC (10 MG) | BNMS | 127,459 | $9,189,307 | 8 |
| 10 | PROCRIT (40000/ML) | BNMS | 4,928 | $8,322,017 | 473 |
| 11 | ARICEPT (10 MG) | SS | 55,055 | $7,718,084 | 33 |
| 12 | ZETIA (10 MG) | SS | 80,251 | $7,684,295 | 20 |
| 13 | LIPITOR (40 MG) | SS | 56,871 | $7,070,422 | 30 |
| 14 | OMEPRAZOLE (20 MG) | Gen | 83,110 | $6,853,502 | 18 |
| 15 | ACIPHEX (20 MG) | SS | 34,785 | $6,818,955 | 75 |
| 16 | AMBIEN (10 MG) | BNMS | 86,389 | $6,427,421 | 17 |
| 17 | ADVAIR DISKUS (250-50MCG) | SS | 61,575 | $6,261,368 | 28 |
| 18 | ACTONEL (35 MG) | SS | 80,734 | $6,198,497 | 19 |
| 19 | TOPROL XL (100 MG) | BNMS | 131,133 | $5,943,605 | 6 |
| 20 | TOPROL XL (50 MG) | BNMS | 204,216 | $5,888,524 | 2 |
* Table IX lists the top 20 drugs ranked by EPIC Payments and number of adjudicated claims for the program year (October 1, 2006-September 30, 2007) as well as the percentage of the totals they represent for the year.
** Drug Type values are BNMS='Brand Name Multi-Source', Gen='Generic' and SS='Sole Source'.
